# Aerosolized and Intravenous Colistin in Healthy Adults

> **NCT01863719** · PHASE1 · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 27 (actual)

## Conditions studied

- Pathogen Resistance
- Pneumococcal Infection
- Pneumonia

## Interventions

- **DRUG:** Colistimethate sodium
- **DRUG:** Colistimethate sodium

## Key facts

- **NCT ID:** NCT01863719
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-08-06
- **Primary completion:** 2017-05-04
- **Final completion:** 2017-05-04
- **Target enrollment:** 27 (ACTUAL)
- **Why stopped:** Completion of cohort 3, safety concerns
- **Last updated:** 2020-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01863719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01863719, "Aerosolized and Intravenous Colistin in Healthy Adults". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01863719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*